Publikationen in Zusammenarbeit mit Forschern von Imperial College London (1)

2023

  1. DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer

    Biomedicines, Vol. 11, Núm. 10